MediciNova (MNOV) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free MNOV Stock Alerts $1.31 -0.01 (-0.76%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media MediciNova Short Interest DataCurrent Short Volume247,000 sharesPrevious Short Volume333,600 sharesChange Vs. Previous Month-25.96%Dollar Volume Sold Short$380,380.00Short Interest Ratio / Days to Cover5.0Last Record DateApril 15, 2024Outstanding Shares49,050,000 sharesFloat Size46,480,000 sharesShort Percent of Float0.53%Today's Trading Volume6,519 sharesAverage Trading Volume31,392 sharesToday's Volume Vs. Average21% Short Selling MediciNova ? Sign up to receive the latest short interest report for MediciNova and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMNOV Short Interest Over TimeMNOV Days to Cover Over TimeMNOV Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> MediciNova Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024247,000 shares $380,380.00 -26.0%0.5%5 $1.54 3/31/2024333,600 shares $483,720.00 +2.3%0.7%6.2 $1.45 3/15/2024326,000 shares $423,800.00 -3.5%0.7%5.6 $1.30 2/29/2024337,800 shares $456,030.00 +34.5%0.7%5.7 $1.35 2/15/2024251,200 shares $339,120.00 +3.3%0.5%4.1 $1.35 1/31/2024243,100 shares $342,771.00 -24.8%0.5%2.1 $1.41 Get the Latest News and Ratings for MNOV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MediciNova and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024323,400 shares $485,100.00 -8.3%0.7%2.8 $1.50 12/31/2023352,600 shares $528,900.00 -6.5%0.8%3.2 $1.50 12/15/2023377,100 shares $588,276.00 +0.5%0.8%3.6 $1.56 11/30/2023375,100 shares $678,931.00 +57.7%0.8%3.8 $1.81 11/15/2023237,800 shares $418,528.00 -2.3%0.5%2.5 $1.76 10/31/2023243,400 shares $464,894.00 -20.7%0.5%11.6 $1.91 10/15/2023307,000 shares $614,000.00 -16.1%0.7%14.3 $2.00 9/30/2023365,700 shares $764,313.00 -1.8%0.8%17.3 $2.09 9/15/2023372,400 shares $759,696.00 +0.8%0.8%19.8 $2.04 8/31/2023369,500 shares $901,580.00 +0.4%0.8%18.1 $2.44 8/15/2023368,100 shares $850,311.00 -0.3%0.8%18.9 $2.31 7/31/2023369,300 shares $878,934.00 -2.1%0.8%20.6 $2.38 7/15/2023377,300 shares $965,888.00 +0.7%0.8%20.6 $2.56 6/30/2023374,800 shares $862,040.00 +5.6%0.8%18.3 $2.30 6/15/2023354,800 shares $819,588.00 +4.7%0.8%18.1 $2.31 5/31/2023339,000 shares $728,850.00 -4.6%0.7%17.6 $2.15 5/15/2023355,400 shares $783,657.00 +1.6%0.8%17.9 $2.21 4/30/2023349,700 shares $737,867.00 -0.6%0.8%16.7 $2.11 4/15/2023351,800 shares $809,140.00 +3.9%0.8%16.4 $2.30 3/31/2023338,700 shares $731,592.00 -1.1%0.7%13.3 $2.16 3/15/2023342,600 shares $719,460.00 -5.4%0.7%7.5 $2.10 2/28/2023362,100 shares $796,620.00 -0.2%0.8%5.4 $2.20 2/15/2023362,800 shares $838,068.00 -3.1%0.8%4.9 $2.31 1/31/2023374,500 shares $895,055.00 -0.9%0.8%4.7 $2.39 1/15/2023377,800 shares $936,944.00 -3.8%0.8%4.6 $2.48 12/30/2022392,700 shares $805,035.00 -25.7%0.9%4.8 $2.05 12/15/2022528,700 shares $1.24 million +20.9%1.1%7.4 $2.35 11/30/2022437,200 shares $1.15 million -34.7%0.9%10.1 $2.64 11/15/2022669,300 shares $1.44 million -17.6%1.4%18.5 $2.15 10/31/2022812,400 shares $1.66 million +0.1%1.8%26.9 $2.04 10/15/2022811,600 shares $1.62 million -15.6%1.8%30.2 $1.99 9/30/2022961,000 shares $2.09 million -11.8%2.1%36 $2.17 9/15/20221,090,000 shares $2.40 million -3.5%2.4%45.4 $2.20 8/31/20221,130,000 shares $2.41 million -1.7%2.4%48.3 $2.13Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> MNOV Short Interest - Frequently Asked Questions What is MediciNova's current short interest? Short interest is the volume of MediciNova shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 247,000 shares of MNOV short. 0.53% of MediciNova's shares are currently sold short. Learn More on MediciNova's current short interest. What is a good short interest ratio for MediciNova? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MNOV shares currently have a short interest ratio of 5.0. Learn More on MediciNova's short interest ratio. Which institutional investors are shorting MediciNova? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of MediciNova: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for MediciNova? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.53% of MediciNova's floating shares are currently sold short. Is MediciNova's short interest increasing or decreasing? MediciNova saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 247,000 shares, a drop of 26.0% from the previous total of 333,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MediciNova's float size? MediciNova currently has issued a total of 49,050,000 shares. Some of MediciNova's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MediciNova currently has a public float of 46,480,000 shares. How does MediciNova's short interest compare to its competitors? 0.53% of MediciNova's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to MediciNova: Rallybio Co. (17.17%), Celularity Inc. (3.73%), Lantern Pharma Inc. (6.33%), Eagle Pharmaceuticals, Inc. (10.32%), Mural Oncology plc (8.08%), Landos Biopharma, Inc. (0.03%), Anebulo Pharmaceuticals, Inc. (0.22%), Immix Biopharma, Inc. (2.53%), HCW Biologics Inc. (0.05%), Equillium, Inc. (2.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short MediciNova stock? Short selling MNOV is an investing strategy that aims to generate trading profit from MediciNova as its price is falling. MNOV shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MediciNova? A short squeeze for MediciNova occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MNOV, which in turn drives the price of the stock up even further. How often is MediciNova's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MNOV, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Rallybio Short Interest Data Celularity Short Interest Data Lantern Pharma Short Interest Data Eagle Pharmaceuticals Short Interest Data Mural Oncology Short Interest Data Landos Biopharma Short Interest Data Anebulo Pharmaceuticals Short Interest Data Immix Biopharma Short Interest Data HCW Biologics Short Interest Data Equillium Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MNOV) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe World's First "$20 Trillion Drug?"Behind the Markets